Hearing News Watch

HEPPENHEIM & BERLIN, GERMANY – There is currently no globally approved drug for the treatment of sudden hearing loss, a condition that affects thousands of individuals each year. However, AudioCure Pharma, a Berlin-based biopharmaceutical company, is advancing research on AC102, an innovative drug candidate that has shown promising results in preclinical and Phase 1 clinical studies. In a significant development,

Palm Beach Gardens, FLORIDA, January 30, 2025 — Leading hearing care retailer HearUSA today announced that the 2025 American Academy of Audiology Foundation Jill Botkin Hearing Health-Care Accessibility Scholarship is now open for nominations. The annual scholarship was created last year in memory of thirty-five year HearUSA employee Jill Botkin, who passed away in 2023. The program is open for applications

MILAN, ITALY — “A Sound Idea”, a new podcast produced by Amplifon in collaboration with Italian podcast production company Chora Media, is now available. The podcast, released in both Italian and English, explores the 75-year history of Amplifon, the world’s leading provider of hearing care services and solutions. The episode recounts the company’s origins, beginning in a basement in downtown

SOMERSET, NEW JERSEY — Oticon, Inc. is now accepting nominations for the 2025 Oticon Focus on People Awards. It is Oticon’s long-standing national program celebrating individuals with hearing loss and the caregivers, educators and professionals who champion their success. This year, the awards will honor three exceptional hearing champions: those who are stamping out stereotypes, advancing care, inclusion and awareness;

MONTPELLIER, FRANCE – Cilcare, a biotechnology company specializing in auditory sciences, has announced the launch of the SAPHIR study (early Stage of Alzheimer’s and Parkinson’s diseases, HearIng Relevance), an observational clinical study examining the relationship between hearing impairments and neurodegenerative diseases, particularly in the early stages of mild cognitive impairment (MCI) and Parkinson’s disease. Conducted in partnership with the University

RESEARCH TRIANGLE PARK, N.C. — Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a specialty pharmaceutical company, has announced that Norgine Pharmaceuticals Ltd., a European specialist pharmaceutical company, has commercially launched PEDMARQSI® (sodium thiosulfate injection) in Germany. Licensing Agreement and Market Expansion In March 2024, Fennec entered into an exclusive licensing agreement under which Norgine will commercialize PEDMARQSI® in Europe, Australia,

MUNSTER, GERMANY – The European Union of Hearing Aid Acousticians (EUHA) has announced the call for entries for the 2025 EUHA Sponsorship Award. Now in its 15th year, the award recognizes outstanding academic work in audiology, hearing aid fitting, and customer benefits. Applications will be accepted until August 15, 2025. “The aim of the EUHA Sponsorship Award is to promote

MILAN, ITALY – Amplifon, a global leader in hearing care solutions and services, has been awarded the Best Performance Award in the Italian Listed Companies category by SDA Bocconi School of Management. The award recognizes companies that have demonstrated excellence in sustainable growth, innovation, and leadership within their respective industries. Now in its eighth edition, the Best Performance Award is

LYNBROOK, NEW YORK – Since establishing Comprehensive Audiology in Lynbrook, New York, eight years ago, Dr. Esther Fogel has prioritized community outreach, offering free hearing screenings in local libraries and supporting children with language-based disabilities. When she learned about Widex’s Community Giveback Day through the Partners in Excellence for You Program, she saw an opportunity to further her efforts. “We

LYNGE, DENMARK – WS Audiology (WSA) announced results for the first quarter of the financial year 2024/25 in line with expectations (October 1, 2024 – December 31, 2024). “With an organic revenue growth of 4%, we are off to a good start of the financial year on a high comparative base from last year. Growth continues to be driven by solid performances across